399 related articles for article (PubMed ID: 32526083)
1. Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19.
Piano S; Dalbeni A; Vettore E; Benfaremo D; Mattioli M; Gambino CG; Framba V; Cerruti L; Mantovani A; Martini A; Luchetti MM; Serra R; Cattelan A; Vettor R; Angeli P;
Liver Int; 2020 Oct; 40(10):2394-2406. PubMed ID: 32526083
[TBL] [Abstract][Full Text] [Related]
2. Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort.
Chaibi S; Boussier J; Hajj WE; Abitbol Y; Taieb S; Horaist C; Jouannaud V; Wang P; Piquet J; Maurer C; Lahmek P; Nahon S
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101556. PubMed ID: 33139241
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.
Moreno-García E; Rico E; Albiach L; Agüero D; Ambrosioni J; Bodro M; Cardozo C; Chumbita M; De la Mora M; García-Pouton N; Garcia-Vidal C; González-Cordón A; Hernández-Meneses M; Inciarte A; Laguno M; Leal L; Linares L; Macay I; Meira F; Mensa J; Moreno A; Morata L; Puerta-Alcalde P; Rojas J; Solá M; Torres B; Torres M; Tomé A; Tuset M; Castro P; Fernández S; Nicolás JM; Almuedo-Riera A; Muñoz J; Fernandez-Pittol M; Marcos MA; Soy D; Martínez JA; García F; Soriano A
Rev Esp Quimioter; 2021 Jun; 34(3):238-244. PubMed ID: 33829722
[TBL] [Abstract][Full Text] [Related]
4. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
[TBL] [Abstract][Full Text] [Related]
5. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.
Weber S; Hellmuth JC; Scherer C; Muenchhoff M; Mayerle J; Gerbes AL
Gut; 2021 Oct; 70(10):1925-1932. PubMed ID: 33514597
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study.
Cattelan AM; Di Meco E; Trevenzoli M; Frater A; Ferrari A; Villano M; Gomiero F; Carretta G; Sasset L
BMC Infect Dis; 2020 Dec; 20(1):934. PubMed ID: 33297986
[TBL] [Abstract][Full Text] [Related]
8. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features of COVID-19-Related Liver Functional Abnormality.
Fan Z; Chen L; Li J; Cheng X; Yang J; Tian C; Zhang Y; Huang S; Liu Z; Cheng J
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1561-1566. PubMed ID: 32283325
[TBL] [Abstract][Full Text] [Related]
10. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
[TBL] [Abstract][Full Text] [Related]
11. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL
Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience.
Voiosu A; Roman A; Pop R; Boeriu A; Popp C; Zurac S; Voiosu T; Dobru D; Mateescu B
Rom J Intern Med; 2022 Mar; 60(1):49-55. PubMed ID: 34253002
[No Abstract] [Full Text] [Related]
13. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
14. A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function Tests.
Gan Q; Gong B; Sun M; Cao Z; Zheng Y; Zhang Y; Wen P; Shen Y; Hong L; Hou T; Jia Y; Li W; Li H; Xie Q
Front Physiol; 2021; 12():642922. PubMed ID: 33815147
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Abnormal Liver Function Tests in COVID-19 Patients at a Tertiary Care Centre.
Kaushik A; Wani SN; Baba MA; Agarwal AK
J Assoc Physicians India; 2020 Aug; 68(8):73-75. PubMed ID: 32738845
[TBL] [Abstract][Full Text] [Related]
16. Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study.
Martínez-Sanz J; Muriel A; Ron R; Herrera S; Pérez-Molina JA; Moreno S; Serrano-Villar S
Clin Microbiol Infect; 2021 Feb; 27(2):238-243. PubMed ID: 32979572
[TBL] [Abstract][Full Text] [Related]
17. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
[TBL] [Abstract][Full Text] [Related]
18. Clinical and therapeutic outcomes of COVID-19 intensive care units (ICU) patients: a retrospective study in Ghana.
Afriyie-Mensah J; Aboagye ET; Ganu VJ; Bondzi S; Tetteh D; Kwarteng E; Akamah J; Doku A; Adjei P
Pan Afr Med J; 2021; 38():107. PubMed ID: 33912277
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
[TBL] [Abstract][Full Text] [Related]
20. Abnormal liver function tests in pregnant patients with COVID-19 - a retrospective cohort study in a tertiary center.
Can E; Oğlak SC; Ölmez F
Ginekol Pol; 2022 Jan; ():. PubMed ID: 35072238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
